SecBot SecBot
144 ·Filed Aug 13, 2026

XFOR

X4 Pharmaceuticals, Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001339498-26-000003
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

No trading signal — this is a mandatory tax-withholding sale that typically occurs in lockstep with RSU settlements. Monitor for any subsequent discretionary Form 4 sales by Chairman Craig, which would carry more weight.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
XFOR ▼ -18.41% at T+20d
NEUTRAL call -18.41% · α vs SPY -16.67% · entry $4.29 → $3.50
Next anchor: T+60d in 10d
Latest observation: T+50 -16.39% FF3 residual α
Entry = T+0 close
Aug 13, 2026
via day close
T+1d
-1.63%
call -1.63% · α -1.43%
$4.22
settled 2mo ago
T+5d
-6.06%
call -6.06% · α -4.10%
$4.03
settled 2mo ago
T+20d
-18.41%
call -18.41% · α -16.67%
$3.50
settled 7w ago
T+60d
Pending
in 10d

Price Chart

Loading chart...

Executive Summary

Chairman Adam Craig filed a Form 144 notice to sell 47,436 shares (~$0.22M) to cover tax withholding on vested RSUs — a mandatory 'sell-to-cover' transaction, not a discretionary trade. The filing is routine and carries no directional signal.

Key Facts

  • Chairman Adam Craig filed Form 144 on 2026-08-13 to sell 47,436 shares of common stock.
  • Estimated proceeds ~$216,071 based on the reported filing; company market cap ~$425M.
  • The sale is mandatory 'sell-to-cover' for RSU tax withholding — not a discretionary trade by the insider.
  • Shares vesting date: 05/11/2026; source of shares: Restricted Stock Unit Vesting (compensation).

Financial Impact

~$216K in proceeds, representing ~0.05% of market cap — negligible dilution impact

sharesOutstanding

Risk Factors

  • Continued insider selling in subsequent periods could signal loss of confidence, though this single filing is routine.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001339498-26-000003
Document: 0001339498-26-000003-index.html0001339498-26-000003
Document: 0001339498-26-000003.txt0001339498-26-000003
15 reports for XFOR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XFOR — sortable, filterable
TypeNow
Oct 8, 2026
18d ago
8-K
MIXED ★ 6/10
$2.91awaiting T+20—$3.25 (+11.68%)
Oct 7, 2026
19d ago
SC 13G/A
NEUTRAL ★ 3/10
$2.81awaiting T+20—$3.25 (+15.66%)
Oct 1, 2026
25d ago
144
NEUTRAL ★ 2/10
$2.83awaiting T+20—$3.25 (+14.84%)
Sep 21, 2026
5w ago
SC 13G
NEUTRAL ★ 4/10
$3.43 $3.02▼ −11.95%▼ −11.39%$3.25 (−5.25%)
Sep 8, 2026
6w ago
8-K
BULLISH ★ 6/10
$3.51 $2.77▼ −20.97%▼ −22.68%$3.25 (−7.28%)
Aug 13, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.22 $3.62▼ −14.22%▼ −12.23%$3.25 (−22.99%)
Aug 13, 2026
10w ago
144
NEUTRAL ★ 2/10
$4.29 $3.50▼ −18.41%▼ −16.67%$3.25 (−24.24%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 2/10
$3.88 $3.96▲ +2.06%▲ +0.17%$3.25 (−16.24%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.88 $3.96▲ +2.06%▲ +0.17%$3.25 (−16.24%)
May 18, 2026
23w ago
EFFECT
NEUTRAL ★ 4/10
$3.68 $4.04▲ +9.78%▲ +8.20%$3.25 (−11.68%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 5h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026